Agenus | Devedores Comerciais





Devedores Comerciais Alterar Data
AbbVie USD 12.77B 132M 2025-09
Agenus USD 354K 53K 2025-03
Amgen USD 9.57B 1.08B 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Celldex Therapeutics USD 90K 0 2025-09
CSL USD 2.97B 638M 2025-06
Dynavax Technologies USD 73.34M 16.79M 2025-06
Eli Lilly USD 19.46B 2.25B 2025-09
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Glaxosmithkline GBP 11.16B 3.46B 2025-09
Incyte USD 1.02B 128.52M 2025-12
Intrexon USD 1.02M 559K 2024-06
J&J USD 17.61B 235M 2025-09
Jiangsu Hengrui CNY 6.26B 64.96M 2025-09
Karyopharm Therapeutics USD 31.78M 6.82M 2024-09
MacroGenics USD 69.23M 56.7M 2025-09
Merck EUR 4.73B 182M 2025-09
Merck USD 12.12B 596M 2025-09
Novartis USD 8.98B 192M 2025-09
Novavax USD 94.96M 62.81M 2024-09
Pfizer USD 18.12B 2.02B 2025-09
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Veracyte USD 47.83M 2.99M 2025-09


Agenus Devedores Comerciais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.